$771 Million is the total value of Iron Triangle Partners LP's 25 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 82.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | New | SPDR S&P 500 ETF TRput | $150,900,000 | – | 400,000 | +100.0% | 19.57% | – |
ABBV | Buy | ABBVIE INC | $53,606,000 | +37.8% | 350,000 | +45.8% | 6.95% | +50.2% |
HUM | New | HUMANA INC | $46,807,000 | – | 100,000 | +100.0% | 6.07% | – |
RGEN | New | REPLIGEN CORP | $40,600,000 | – | 250,000 | +100.0% | 5.26% | – |
GH | Buy | GUARDANT HEALTH INC | $39,960,000 | -16.5% | 990,568 | +37.2% | 5.18% | -8.9% |
BSX | New | BOSTON SCIENTIFIC CORP | $37,270,000 | – | 1,000,000 | +100.0% | 4.83% | – |
DXCM | Buy | DEXCOM INC | $37,265,000 | +4.1% | 500,000 | +614.3% | 4.83% | +13.4% |
ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $37,197,000 | +12.9% | 550,000 | +9.4% | 4.82% | +23.1% |
ICLR | Sell | ICON PLC | $34,672,000 | -46.7% | 160,000 | -40.2% | 4.50% | -41.9% |
NBIX | New | NEUROCRINE BIOSCIENCES INC | $34,118,000 | – | 350,000 | +100.0% | 4.42% | – |
HQY | Sell | HEALTHEQUITY INC | $29,807,000 | -9.2% | 485,541 | -0.3% | 3.86% | -1.0% |
AZN | Buy | ASTRAZENECA PLCsponsored adr | $28,904,000 | +14.7% | 437,477 | +15.1% | 3.75% | +25.0% |
BIO | New | BIO RAD LABS INCcl a | $28,688,000 | – | 57,955 | +100.0% | 3.72% | – |
LEGN | New | LEGEND BIOTECH CORPsponsored ads | $27,243,000 | – | 495,329 | +100.0% | 3.53% | – |
CNMD | Buy | CONMED CORP | $24,898,000 | +4.4% | 260,000 | +62.0% | 3.23% | +13.9% |
CI | New | CIGNA CORP NEW | $21,082,000 | – | 80,000 | +100.0% | 2.73% | – |
INSP | New | INSPIRE MED SYS INC | $20,813,000 | – | 113,938 | +100.0% | 2.70% | – |
ESTA | New | ESTABLISHMENT LABS HLDGS INC | $17,674,000 | – | 325,008 | +100.0% | 2.29% | – |
MASS | Buy | 908 DEVICES INC | $17,502,000 | +29.1% | 850,000 | +19.2% | 2.27% | +40.8% |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $11,964,000 | -77.4% | 150,000 | -70.2% | 1.55% | -75.4% |
OHPAU | ORION ACQUISITION CORPunit 02/19/2026 | $9,805,000 | -0.1% | 999,513 | 0.0% | 1.27% | +8.9% | |
SGRY | Sell | SURGERY PARTNERS INC | $7,756,000 | -64.8% | 268,176 | -33.0% | 1.01% | -61.6% |
KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $4,961,000 | -66.3% | 1,100,000 | -45.0% | 0.64% | -63.3% |
Sell | SOMALOGIC INC | $4,520,000 | -68.2% | 1,000,000 | -43.5% | 0.59% | -65.3% | |
STXS | Sell | STEREOTAXIS INC | $3,140,000 | -50.8% | 1,706,688 | -0.3% | 0.41% | -46.4% |
NVST | Exit | ENVISTA HOLDINGS CORPORATION | $0 | – | -300,000 | -100.0% | -1.74% | – |
SGEN | Exit | SEAGEN INC | $0 | – | -130,000 | -100.0% | -2.23% | – |
GDRX | Exit | GOODRX HLDGS INC | $0 | – | -1,089,677 | -100.0% | -2.50% | – |
ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -50,000 | -100.0% | -2.59% | – |
NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -722,395 | -100.0% | -2.99% | – |
ICUI | Exit | ICU MED INC | $0 | – | -136,313 | -100.0% | -3.61% | – |
MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -100,000 | -100.0% | -3.97% | – |
UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -190,073 | -100.0% | -4.06% | – |
HOLX | Exit | HOLOGIC INC | $0 | – | -480,000 | -100.0% | -4.39% | – |
ILMN | Exit | ILLUMINA INC | $0 | – | -110,000 | -100.0% | -4.57% | – |
NVRO | Exit | NEVRO CORP | $0 | – | -562,833 | -100.0% | -4.84% | – |
CTLT | Exit | CATALENT INC | $0 | – | -392,663 | -100.0% | -5.18% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -90,014 | -100.0% | -5.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
ICON PLC | 10 | Q3 2023 | 11.7% |
BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
NEVRO CORP | 10 | Q1 2022 | 6.7% |
DEXCOM INC | 10 | Q3 2023 | 7.7% |
ABBVIE INC | 9 | Q3 2023 | 8.1% |
ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.